Augmentation of Endogenous 2-Arachidonoylglycerol Mitigates Autistic Behaviors of BTBR Mice
- 6 November 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (4) , 5022-5038
Abstract
The lipid-based endocannabinoid (eCB) system regulates a host of developmental, physiological, and pathological processes in the mammalian brain, and recent studies have suggested that dysfunction of eCB system may contribute to the neuropathology of autism spectrum disorder (ASD). However, specific contributions to ASD-related developmental, cognitive, and behavioral phenotypes remain largely unexplored. The current study was designed to investigate if enhancing eCB signaling by blocking 2-arachidonoylglycerol (2-AG) hydrolase can mitigate ASD-like behaviors in a mouse model, and if such effects are associated with suppression of inflammatory signaling, oxidative stress, or neuronal apoptosis. Intraperitoneal injection of the 2-AG hydrolase monoacylglycerol lipase (MAGL) JZL184 (4, 16, or 40 mg/kg) elevated 2-AG and reversed eCB system metabolic enzymes and receptors expression deficits in BTBR T + ltpr3tf/J (BTBR) mouse model of ASD. Moreover, the hyperactivity, excessive stereotypy, impaired social behavior, and cognitive deficits characteristic of this animal model were significantly improved by JZL184. Concomitantly, JZL184 administration reversed the abnormal pro- and anti-inflammatory cytokine concentrations measured in the hippocampus of BTBR mice. In addition, JZL184 reversed the observed overexpression of pro-apoptotic Bax and underexpression of anti-apoptotic Bcl-2 in BTBR mice and enhanced neuronal numbers in hippocampal CA1 and CA3 regions. We also found that the behavioral test battery influenced eCB concentrations independently of JZL184 treatment. Collectively, these findings suggest that augmenting eCB signaling can mitigate ASD-related phenotypes by suppressing neuroinflammation and neuronal apoptosis.Keywords
Funding Information
- Natural Science Foundation of Heilongjiang Province (LH2021H014)
- University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (UNPYSCT-2020168)
This publication has 74 references indexed in Scilit:
- Cannabidiol for the treatment of autism spectrum disorder: hope or hype?Psychopharmacology, 2022
- Acid‐Responsive Dual‐Targeted Nanoparticles Encapsulated Aspirin Rescue the Immune Activation and Phenotype in Autism Spectrum DisorderAdvanced Science, 2022
- Communication and social interaction in the cannabinoid‐type 1 receptor null mouse: Implications for autism spectrum disorderAutism Research, 2021
- Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer’s DiseaseMolecular Neurobiology, 2021
- Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL‐α, induces autism spectrum disorder‐like and co‐morbid phenotypes in adult C57BL/J miceAutism Research, 2021
- Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 YearsNeuroscience Bulletin, 2020
- 2‐AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCsGlia, 2018
- Lack of hippocampal CB1 receptor desensitization by Δ9-tetrahydrocannabinol in aged mice and by low doses of JZL 184Naunyn-Schmiedeberg's Archives of Pharmacology, 2016
- Cannabinoid Receptor 1 Signaling in Embryo NeurodevelopmentBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2012
- Short‐term and long‐term survival of new neurons in the rat dentate gyrusJournal of Comparative Neurology, 2003